PMCB vs UBER · $8.6M cap vs P/E 18, rev $52.02B
PharmaCyte Biotech Inc (PMCB) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
PMCB currently screens at market cap $8.6M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the PMCB and UBER stock pages for the full models.
Not investment advice.